性别作为IgG4相关性疾病临床表型的预测因素和免疫反应的决定因素:一项符合美国风湿病学会-欧洲抗风湿病联盟分类标准患者的回顾性研究
该回顾性单中心队列研究纳入328例符合ACR-EULAR分类标准的IgG4相关性疾病患者,发现男性占69%,男女比2.2:1,显著高于风湿科门诊人群的0.4:1(p<0.001)。男性诊断年龄更大、分类标准评分更高、胰腺和肾脏受累比例更高、血清学异常更常见、循环浆母细胞扩增更明显。
要点
- 男性占IgG4-RD患者的69%,男女比2.2:1,与风湿科门诊人群的0.4:1形成鲜明对比(p<0.001)。
- 男性诊断年龄平均比女性大5.5岁(63.7岁 vs 58.2岁;p=0.0031)。
- 男性胰腺受累比例为50%,女性约26%(p<0.0001)。
核心结论
- IgG4相关性疾病在自身免疫病中不寻常,更易影响男性,并呈现显著的性别依赖性器官分布和B细胞反应程度。
研究设计与样本
- 回顾性单中心队列研究,从马萨诸塞州总医院风湿科诊所IgG4相关性疾病登记处招募患者。
- 纳入2008年1月至2023年5月期间符合ACR-EULAR分类标准的328例患者。
- 收集诊断时年龄、基线器官受累、治疗状态和治疗前实验室值,用流式细胞术定量循环浆母细胞和B细胞亚群。
- 活动性疾病定义为IgG4相关性疾病应答指数评分大于0。
主要发现
- 328例纳入患者中男性226例(69%)、女性102例(31%),男女比2.2:1,显著高于风湿科门诊人群的0.4:1(p<0.001)。
- 男性诊断年龄平均比女性大5.5岁(63.7岁 vs 58.2岁;p=0.0031)。
- 男性基线ACR-EULAR分类标准评分中位数35.0(IQR 28.0-46.0),女性29.5(25.0-39.0)(p=0.0010)。
- 男性胰腺受累比例为50%,女性约26%(p<0.0001)。
- 男性基线血清学异常更常见,IgG4值分布存在显著性别差异且男性更高,男性更常见浆母细胞扩增定义的血液活动性B细胞反应。
关键数值与推荐
- 活动性疾病定义为IgG4相关性疾病应答指数评分大于0。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: IgG4-related disease is a multiorgan fibroinflammatory disease considered to have an autoimmune origin. Case series describing individual organ involvement have suggested differences in phenotypic expression between males and females. We aimed to characterise differences in IgG4-related disease manifestations between male and female patients in a large single-centre cohort. METHODS: In this retrospective, single-centre cohort study, patients were recruited from the Massachusetts General Hospital Rheumatology Clinic (Boston, MA, USA) and classified according to the American College of Rheumatology-European Alliance of Associations for Rheumatology (ACR-EULAR) classification criteria. Only patients satisfying the ACR-EULAR classification criteria were included in the study. Data on age at diagnosis, organ involvement at baseline, treatment status, and pre-treatment laboratory values were collected. Circulating plasmablasts and B-cell subsets were quantitated by flow cytometry. Active disease was defined by an IgG4-related disease Responder Index score of more than 0. Laboratory values were analysed for patients who were untreated at baseline and had active IgG4-related disease. The main outcomes were assessed in all participants with available data. FINDINGS: Of the 564 participants enrolled in the Massachusetts General Hospital Rheumatology Clinic IgG4-related disease Registry, 328 fulfilled ACR-EULAR classification criteria and were included between January, 2008, and May, 2023. There was a strong male predominance (male:female ratio 2·2:1) with 226 (69%) males and 102 (31%) females, which contrasted markedly with our general rheumatology clinic population (0·4:1; p<0·001). The male predominance increased with each decade of life starting at age 40 years. On average, male patients were 5·5 years older at diagnosis than female patients (63·7 years vs 58·2 years; p=0·0031). We observed male patients to have higher ACR-EULAR classification criteria scores at baseline with a median score of 35·0 (IQR 28·0-46·0), compared with 29·5 (25·0-39·0) for females (p=0·0010). The proportion of male patients with pancreatic and renal involvement was almost double the proportion observed in female patients (50% of the male patients had pancreatic involvement, compared with about 26% of the female patients; p<0·0001). Male patients were more likely to have serological abnormalities at baseline. The distribution of IgG4 values differed significantly between male an female sexes, favouring higher values in males. We found that male patients with IgG4-related disease were more likely to have active B-cell responses in the blood as defined by plasmablast expansions. INTERPRETATION: IgG4-related disease is unusual among autoimmune diseases in that it is more likely to affect males than females and to present with a striking sex-dependent organ distribution and degree of B-cell response. These findings highlight important variation between IgG4-related disease and other conditions generally believed to have an autoimmune basis. Most autoimmune diseases, by contrast to IgG4-related disease, demonstrate pronounced predilections for affecting females more frequently than males. Hypotheses surrounding the cause and pathophysiology of this condition need to consider this unusual sex distribution among patients with IgG4-related disease. FUNDING: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Rheumatology Research Foundation, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
引用
- Jha I, McMahon GA, Perugino CA, et al. Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology-European League Against Rheumatism classification criteria. Lancet Rheumatol. 2024. PMID: 38824935. doi:10.1016/S2665-9913(24)00089-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。